The CHLA-developed app will collect data for future research in machine learning to detect sleep disorders and help advance the standards of pediatric care in pain and sleep medicine Children’s ...
After notching a phase 2 trial win, Idorsia’s insomnia med Quviviq (daridorexant) is one step closer to potentially becoming a first-in-class treatment for children. | After notching a phase 2 trial ...
LITTLETON, Colo., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (VVOS), a leading medical device and technology company specializing in the development and commercialization of highly ...
Ad hoc announcement pursuant to Art. 53 LR Phase 2 results show a statistically significant dose-dependent response on total ...
Racially and ethnically diverse children exhibit worse sleep outcomes than White children, influenced by structural and cultural factors. Sleep variability/regularity ...
Children’s Hospital Los Angeles has launched the nation’s first pediatric sleep registry using Apple Watch technology, along with a new data collection app aimed at transforming how sleep disorders ...
LITTLETON, Colo., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the ...
Pediatric concussions are a growing concern, particularly among youth engaged in sports and other high-risk activities. While much research has focused on cognitive rest and physical recovery, recent ...
A new study conducted by University Hospitals Connor Whole Health highlights the impact of pediatric integrative medicine services. This unique self-governed program, operating within UH Rainbow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results